Interestingly, knockdown of HOXA5 inhibits cellular differentiation in retinal-treated colon tumors, suggesting that HOXA5 is a candidate master regulator of intestinal differentiation in colon cancer. Here, HOXA5 is linked to colonic neoplasm.